Samyang Biopharm Corporation

₩42,500As of Sun 8 Nov 2026, 12:00 UTC

KRX:0120G0Healthcare

Country South Korea

PE (Fwd) •••

TSR 10Y CAGR —

Div yield —

ROE —

Medical Devices

Beta (5Y) —

PE TTM —

TSR TTM —

Mkt cap ₩316.0B

ROIC —

SE Grade™

Value

Quality

Moat

Consensus

Reference

₩46,698

9.88%

(91.49%)

Hold 7|7|7|0|3

TTM

FYE 31 Dec KRW

FY2016

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

56.63

Revenue₩B

28.12

29.46

31.56

33.81

36.74

39.62

41.40

43.25

46.13

49.03

57.98

5.94%

6.37%

19.28

Revenue growth%

29.21

28.52

30.97

31.40

30.47

30.21

31.37

30.39

31.94

33.99

2.95

31.37

30.72

27.89

Gross margin%

26.61

29.41

31.11

31.94

32.17

32.11

33.96

34.74

32.09

33.21

16.85

33.21

32.10

7.64

Operating margin%

4.51

7.44

8.01

10.22

10.84

11.71

13.93

12.42

12.24

15.20

28.30

12.42

11.27

12.30

Net margin%

7.88

9.63

7.73

8.98

7.03

6.94

3.97

5.15

5.50

4.13

5.06

5.15

6.99

7.488

P/E ratio (avg)x

32.28

32.66

30.41

29.56

33.09

35.56

34.43

35.99

38.26

40.68

19.56

35.99

33.76

27.59

EV/EBITx

26.63

29.04

26.16

24.22

22.38

24.35

25.04

22.77

22.21

20.14

18.57

22.77

24.28

10.03

FCF yield (avg)%

5.84

7.00

5.75

3.74

6.17

4.96

7.93

7.52

5.71

3.96

15.25

5.71

5.80

23.25

FCF margin%

6.38

5.45

4.65

5.95

8.37

6.28

4.21

2.13

2.42

4.74

7.72

4.21

5.10

0.127

FCF / Net incomex

1.402

1.320

1.371

1.287

1.341

1.364

1.429

1.457

1.469

1.435

1.242

1.435

1.387

7.95

ROIC%

29.67

29.52

26.84

27.72

28.24

26.29

27.53

25.28

27.38

28.94

16.55

27.38

27.63

25.44

Return on equity%

4.20

3.44

5.81

7.46

6.64

8.10

7.90

10.65

10.94

10.07

28.14

10.07

7.68

28.25

Return on assets%

22.31

19.68

18.77

18.61

16.28

16.47

18.47

16.75

19.58

20.69

20.67

18.47

18.69

5,607

EPS₩

4,563

5,268

5,417

6,013

6,664

6,352

6,184

6,354

6,094

6,248

(1.77%)

3.73%

—

12.27

EPS growth%

17.97

17.21

15.69

16.75

15.51

16.48

14.35

14.42

14.98

16.91

14.50

14.98

16.09

3,570

Bookvalue per sh₩

2,391

2,376

2,512

2,769

3,122

3,368

3,760

4,007

4,537

4,615

2,829

8.13%

8.12%

—

5,470

FCF per share₩

3,852

3,645

3,253

3,397

3,194

3,144

2,889

3,058

3,354

3,090

2,101

(0.66%)

(3.23%)

—

4,858

Dividend per sh₩

5,047

5,799

5,737

6,358

6,774

6,879

7,170

7,206

7,285

7,275

1,769

1.44%

5.13%

—

10.23

Div yield (avg)%

22.60

24.21

22.46

24.43

24.40

25.59

25.15

25.17

27.27

27.88

20.61

25.59

24.79

7.73

Payout ratio%

2.93

0.40

0.91

3.65

3.91

1.42

1.41

1.31

4.28

6.37

28.60

1.42

2.17

7.250

Shares (diluted)M

7.406

7.073

7.269

6.706

6.090

5.844

6.227

6.542

5.696

5.392

7.314

(2.40%)

(2.94%)

10.57

Buyback yield%

6.84

9.76

10.72

10.99

9.42

12.07

12.63

12.93

13.82

11.60

28.10

12.63

11.29

0.832

D/E ratiox

1.766

1.981

2.044

1.982

2.287

2.516

2.830

3.012

3.475

3.599

0.723

3.012

2.402

6.595

Enterprise value₩B

4.805

4.570

5.172

4.743

5.339

5.983

5.864

6.186

5.904

5.759

60.68

1.52%

1.31%

37.43

LT debt₩B

22.48

22.36

23.69

23.88

28.28

31.35

30.79

35.31

37.86

42.25

59.75

8.36%

7.93%

Peers (US$206.1M)

Cap (US$)

WON TECH Co.,Ltd.

227.4M

7.838x

ToolGen Incorporated

203.2M

—

Curexo Inc.

199.9M

49.40x

United Orthopedic…

207.7M

12.99x

Capital

TTM

10Y

Leveragex

1.309

(0.237)

(0.190)

EBIT/Intx

0.537

0.064

Own earn%

20.24

21.10

23.55

Sh yield%

20.80

38.10

36.54

Owners

Insiders/Inst%

12.42

25.28

Short interest%

2.05

SBC / revenue%

2.59

Record

10Y

Profitable years

10/10

Revenue growth years

10/10

EPS growth years

10/10

Dividend streakyrs

Op margin range%

5–15

$1 testx

—

Incr. ROIC%

Samyang Biopharm Corporation offers pharmaceutical and biotech products. The company was founded in 2011 and is based in Seoul, South Korea.

Growth vs revenue

Latest

Trend

10Y CAGR

Rel growth

Revenue

₩49.03B

6.37%

1.00×

Cost of revenue

₩34.32B

6.43%

1.00×

Operating expenses

₩9.816B

6.23%

0.99×